These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31523957)

  • 21. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
    Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
    Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.
    Sharma VK; Alipour A; Soran-Erdem Z; Aykut ZG; Demir HV
    Nanoscale; 2015 Jun; 7(23):10519-26. PubMed ID: 26010145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal-clearable zwitterionic conjugated hollow ultrasmall Fe
    Liu W; Deng G; Wang D; Chen M; Zhou Z; Yang H; Yang S
    J Mater Chem B; 2020 Apr; 8(15):3087-3091. PubMed ID: 32207500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine.
    Shapiro MG; Westmeyer GG; Romero PA; Szablowski JO; Küster B; Shah A; Otey CR; Langer R; Arnold FH; Jasanoff A
    Nat Biotechnol; 2010 Mar; 28(3):264-70. PubMed ID: 20190737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
    Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
    Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineered core-shell magnetic nanoparticle for MR dual-modal tracking and safe magnetic manipulation of ependymal cells in live rodents.
    Peng YK; Lui CNP; Chen YW; Chou SW; Chou PT; Yung KKL; Tsang SCE
    Nanotechnology; 2018 Jan; 29(1):015102. PubMed ID: 29205171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
    Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
    Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels.
    Sillerud LO
    Int J Nanomedicine; 2016; 11():357-71. PubMed ID: 26855574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superparamagnetic nanoparticle-enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization.
    Tafoya MA; Madi S; Sillerud LO
    J Magn Reson Imaging; 2017 Aug; 46(2):574-588. PubMed ID: 27875002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial Organization of Superparamagnetic Iron Oxide Nanoparticles in/on Nano/Microsized Carriers Modulates the Magnetic Resonance Signal.
    Lee MK; Clay NE; Ko E; Smith CE; Chen L; Cho N; Sung HJ; DiPietro L; Lee J; Kong H
    Langmuir; 2018 Dec; 34(50):15276-15282. PubMed ID: 30458616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes loaded with hydrophilic magnetite nanoparticles: Preparation and application as contrast agents for magnetic resonance imaging.
    German SV; Navolokin NA; Kuznetsova NR; Zuev VV; Inozemtseva OA; Anis'kov AA; Volkova EK; Bucharskaya AB; Maslyakova GN; Fakhrullin RF; Terentyuk GS; Vodovozova EL; Gorin DA
    Colloids Surf B Biointerfaces; 2015 Nov; 135():109-115. PubMed ID: 26241922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gold-coated iron oxide nanoparticles as a T2 contrast agent in magnetic resonance imaging.
    Ahmad T; Bae H; Rhee I; Chang Y; Jin SU; Hong S
    J Nanosci Nanotechnol; 2012 Jul; 12(7):5132-7. PubMed ID: 22966533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
    Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
    Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin.
    Atanasijevic T; Shusteff M; Fam P; Jasanoff A
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14707-12. PubMed ID: 17003117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic particle imaging with tailored iron oxide nanoparticle tracers.
    Ferguson RM; Khandhar AP; Kemp SJ; Arami H; Saritas EU; Croft LR; Konkle J; Goodwill PW; Halkola A; Rahmer J; Borgert J; Conolly SM; Krishnan KM
    IEEE Trans Med Imaging; 2015 May; 34(5):1077-84. PubMed ID: 25438306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.
    Wei H; Bruns OT; Kaul MG; Hansen EC; Barch M; Wiśniowska A; Chen O; Chen Y; Li N; Okada S; Cordero JM; Heine M; Farrar CT; Montana DM; Adam G; Ittrich H; Jasanoff A; Nielsen P; Bawendi MG
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2325-2330. PubMed ID: 28193901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paramagnetic nanoparticle T1 and T2 MRI contrast agents.
    Xu W; Kattel K; Park JY; Chang Y; Kim TJ; Lee GH
    Phys Chem Chem Phys; 2012 Oct; 14(37):12687-700. PubMed ID: 22885983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging.
    Medarova Z; Balcioglu M; Yigit MV
    Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.